Literature DB >> 32540612

Laser excision of oral leukoplakia: Does it affect recurrence and malignant transformation? A systematic review and meta-analysis.

Mariana de Pauli Paglioni1, Cesar Augusto Migliorati2, Isabel Schausltz Pereira Faustino3, Bruno Augusto Linhares Almeida Mariz3, Ana Luiza Oliveira Corrêa Roza3, Pablo Agustin Vargas3, Adriana Franco Paes Leme4, Thaís Bianca Brandão5, Ana Carolina Prado Ribeiro5, Marcio Ajudarte Lopes3, Alan Roger Santos-Silva3.   

Abstract

Oral leukoplakia (OL) is a white lesion with high potential of recurrence and malignant transformation. The variable clinical and histopathological features of OL may potentially impact both treatment and prognosis. Current literature shows that post treatment rates of recurrence and malignant transformation vary widely. The use of surgical lasers have been proposed with the objective of improving outcomes. We performed a systematic review and a comprehensive meta-analysis dedicated to pooling the rates of recurrence and malignant transformation of OL lesions treated using the main types of surgical lasers available. Scopus, MEDLINE/PubMed, and Embase were searched electronically. A total of 36 articles met the inclusion criteria. Selected studies included OL lesions that were treated by evaporation or excision using Nd:YAG laser, Er:YAG laser, CO2 laser, KTP laser, or diode laser. The results of this systematic review and meta-analysis suggest that surgical laser excision of OL may decrease recurrence rates but have no effect on the malignant transformation of OL when compared with conventional treatments.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Laser; Laser surgery; Leukoplakia; Meta-analysis; Oral leukoplakia; Prognosis; Recurrence; Systematic review; Treatment outcome

Year:  2020        PMID: 32540612     DOI: 10.1016/j.oraloncology.2020.104850

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  6 in total

Review 1.  Clinical assessment for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults.

Authors:  Tanya Walsh; Saman Warnakulasuriya; Mark W Lingen; Alexander R Kerr; Graham R Ogden; Anne-Marie Glenny; Richard Macey
Journal:  Cochrane Database Syst Rev       Date:  2021-12-10

2.  Expression of p53, p63, podoplanin and Ki-67 in recurring versus non-recurring oral leukoplakia.

Authors:  Jonas Sundberg; Sushma Pandey; Daniel Giglio; Erik Holmberg; Göran Kjeller; Anikó Kovács; Lars Peter Sand; Burcu Tokozlu; Jenny Öhman; Dipak Sapkota; Bengt Hasséus
Journal:  Sci Rep       Date:  2021-10-21       Impact factor: 4.379

3.  Azoxystrobin induces apoptosis via PI3K/AKT and MAPK signal pathways in oral leukoplakia progression.

Authors:  Lingyu Li; Jing Li; Hui Chen; Yajun Shen; Yunping Lu; Min Zhang; Xiaofei Tang
Journal:  Front Pharmacol       Date:  2022-08-04       Impact factor: 5.988

4.  Management of oral leukoplakia by ablative fractional laser-assisted photodynamic therapy: A 3-year retrospective study of 48 patients.

Authors:  Yi-Lin Yao; Yu-Feng Wang; Chen-Xi Li; Lan Wu; Guo-Yao Tang
Journal:  Lasers Surg Med       Date:  2022-03-07

5.  Recurrence in Oral Premalignancy: Clinicopathologic and Immunohistochemical Analysis.

Authors:  Maria Georgaki; Dimitris Avgoustidis; Vasileios Ionas Theofilou; Evangelia Piperi; Efstathios Pettas; Demos G Kalyvas; Dimitrios Vlachodimitropoulos; Christos Perisanidis; Andreas C Lazaris; Nikolaos G Nikitakis
Journal:  Diagnostics (Basel)       Date:  2021-05-12

6.  Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions.

Authors:  Tanya Walsh; Richard Macey; Alexander R Kerr; Mark W Lingen; Graham R Ogden; Saman Warnakulasuriya
Journal:  Cochrane Database Syst Rev       Date:  2021-07-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.